Literature DB >> 16369385

"Good Publication Practice for Pharmaceutical Companies": where are we now?

Elizabeth Wager1.   

Abstract

Eighteen months on from the publication of "Good Publication Practice for Pharmaceutical Companies," one member of the working group that developed these guidelines reflects on what they have achieved and what has changed since they were first developed.

Mesh：

Year:  2005        PMID： 16369385      PMCID： PMC1681611     

Source DB:  PubMed          Journal:  MedGenMed        ISSN： 1531-0132


  14 in total

Review 1.  Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications.

Authors:  Hans Melander; Jane Ahlqvist-Rastad; Gertie Meijer; Björn Beermann
Journal:  BMJ       Date:  2003-05-31

2.  Good publication practice for pharmaceutical companies.

Authors:  Elizabeth Wager; Elizabeth A Field; Leni Grossman
Journal:  Curr Med Res Opin       Date:  2003       Impact factor: 2.580

3.  Good publication practices for pharmaceutical companies: why we need another set of guidelines.

Authors:  Elizabeth Wager; Elizabeth A Field; Leni Grossman
Journal:  Curr Med Res Opin       Date:  2003       Impact factor: 2.580

4.  Pfizer pleads guilty, but drug sales continue to soar.

Authors:  Jeanne Lenzer
Journal:  BMJ       Date:  2004-05-22

5.  Clinical trial registration: a statement from the International Committee of Medical Journal Editors.

Authors:  Catherine De Angelis; Jeffrey M Drazen; Frank A Frizelle; Charlotte Haug; John Hoey; Richard Horton; Sheldon Kotzin; Christine Laine; Ana Marusic; A John P M Overbeke; Torben V Schroeder; Hal C Sox; Martin B Van Der Weyden
Journal:  Lancet       Date:  2004 Sep 11-17       Impact factor: 79.321

6.  The need for trial identifiers.

Authors:  Elizabeth Wager
Journal:  Curr Med Res Opin       Date:  2004       Impact factor: 2.580

7.  Impact of covert duplicate publication on meta-analysis: a case study.

Authors:  M R Tramèr; D J Reynolds; R A Moore; H J McQuay
Journal:  BMJ       Date:  1997-09-13

8.  A ghostly crew.

Authors:  D Sharp
Journal:  Lancet       Date:  1998-04-11       Impact factor: 79.321

9.  Improving the quality of reporting of randomized controlled trials. The CONSORT statement.

Authors:  C Begg; M Cho; S Eastwood; R Horton; D Moher; I Olkin; R Pitkin; D Rennie; K F Schulz; D Simel; D F Stroup
Journal:  JAMA       Date:  1996-08-28       Impact factor: 56.272

10.  Underreporting research is scientific misconduct.

Authors:  I Chalmers
Journal:  JAMA       Date:  1990-03-09       Impact factor: 56.272
View more
  1 in total

1.  Bidirectional conflicts of interest involving industry and medical journals: who will champion integrity?

Authors:  William L Lanier
Journal:  Mayo Clin Proc       Date:  2009-09       Impact factor: 7.616
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.